Examination of the biomark assay as an alternative to oncotype DX for defining chemotherapy benefit

Jinkyoung Kim, Aeree Kim, Chungyeul Kim

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Examination of the biomark assay as an alternative to oncotype DX for defining chemotherapy benefit'. Together they form a unique fingerprint.

Medicine & Life Sciences